Kaie Pruunsild
Tallinn, Estonia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
Journal: Cancer chemotherapy and pharmacology
Published: January 20, 2021
Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia.
Journal: Blood
Published: February 04, 2020
Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.
Journal: Leukemia
Published: December 12, 2019
Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
Journal: Journal of neuro-oncology
Published: July 16, 2019
Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.
Journal: Leukemia
Published: September 04, 2018
Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008.
Journal: British journal of haematology
Published: July 07, 2018
Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy.
Journal: Cancer chemotherapy and pharmacology
Published: June 26, 2018
NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia.
Journal: Leukemia
Published: March 29, 2018
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.
Journal: Leukemia
Published: May 02, 2017
Children with low-risk acute lymphoblastic leukemia are at highest risk of second cancers.
Journal: Pediatric blood & cancer
Published: December 04, 2016
Last Updated: 09/26/2026